Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis-Reference-Cited by-同舟云学术

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis

Published:2016-03 Issue:3 Volume:6 Page:e008671
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Sruamsiri Rosarin,Wagner Anita K,Ross-Degnan Dennis,Lu Christine Y,Dhippayom Teerapon,Ngorsuraches Surachat,Chaiyakunapruk Nathorn

Publisher

BMJ

Subject

General Medicine

Reference36 articles.

1. Office of the National Economic and Social Development Board. Thailand Health expenditure 2002–2013. Secondary Thailand Health expenditure 2002–2013. 2013. http://social.nesdb.go.th/SocialStat/StatReport_Final.aspx?reportid=256&template=1R2C&yeartype=M&subcatid=18

2. Bureau of Policy and Strategy; Ministry of Public Health. Thailand health profile report 2008–2010. Bangkok: Bureau of Policy and Strategy, Ministry of Public Health, 2007.

3. PHP44 international comparison of pharmaceutical expenditure in middle income countries: methodological questions;Kalo;Value Health,2012

4. The National Health Security Office. Quarterly annual report. Nonthaburi, 2013.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis;BMC Health Services Research;2024-01-17

2. Prevalence and risk factors of vitamin D deficiency among living with HIV adults receiving antiretroviral treatment in tropical area: Cross-sectional study;Heliyon;2023-09

3. Anticancer medicines in Pakistan: An analysis of essential medicines lists;Journal of Oncology Pharmacy Practice;2023-04-02

4. Effect on mortality of inclusion of drugs in Thailand's National List of Essential Medicines, 2005–2016;Health Policy and Technology;2023-03

5. Equity in Access to and Quality Use of Medicines in Low- and Middle-Income Countries;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023